MET and pancreatic insulinoma: Desai et al.13, 19 found that GSK-3 stabilizes and phosphorylates MNX1 protein in insulinoma cells and that phospho-MNX1 can activate the oncogenic c-Met pathway by suppressing the c-Met inhibitor Cblb.